Back to Search
Start Over
DNA methylation is a key determinant of response to targeted and immune checkpoint therapies in metastatic renal cell carcinoma.
- Source :
- Genomics & Genetics Weekly; 11/22/2024, p245-245, 1p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 15316467
- Database :
- Supplemental Index
- Journal :
- Genomics & Genetics Weekly
- Publication Type :
- Periodical
- Accession number :
- 180890644